Abstract
There has been a recent tendency to reduce the different forms of hyperlipidemia to fewer categories and to attempt a more unified approach to the dietary management of the hyperlipidemias(l). There is some justification for this approach, but the H.G.H.McMaster Lipid Research Clinic still uses the internationally accepted World Health Organization classification(2) based on Fredrickson et al. This is because we believe that this classification of hyperlipoproteinemia(HLP) with, all its imperfections has etiological, genetic, epidemiological, diagnostic and therapeutic potential. It should be remembered that in all 5 types of hyperlipoproteinemia that plasma cholesterol levels may be elevated, although this is most commonly seen in types IIa and b, III and IV HLP. The majority of this discussion will be devoted to the one parameter namely plasma lipids, which are routinely measured in the Lipid Clinic. No attempt will be made to elaborate on other important cholesterol pools--the liver, the intestine and its contents, adipose tissue and other tissue stores.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beaumont JL, Carlson LA, Cooper GR, et al: Classification of hyperlipidemias and hyperlipoproteinaemias. W.H.O. Bull. 43: 891–915, 1970.
Tabaqchali S, Chait A, Harrison R, et al; Experience with simplified scheme of treatment of hyperlipidaemia. Brit. Hed. J. 3: 377–380, 1974.
The Coronary Drug Project Research Group: Clofibrate and Niacin in coronary heart disease. JAMA 231: 360–381, 1975.
Oliver MF: A primary prevention trial using Clofibrate (Atromid-S) in Drugs Affecting Lipid Metabolism (Ed. W.L. Holmes et al) Plenum Press, New York 1969 p. 339–344.
Little JA: The National Heart and Lung Institute Lipid Research Clinic program at Toronto-McMaster University. Canad. J. Pub. Health 65: 378–383, 1974.
Mishkel, MA: Pseudohomozygous and pseudoheterozygous type II hyperlipoproteinemia. Amer J. Dis. Children (in press).
Nazir DJ, Mishkel MA: The effect of calcium on plasma lipids and bile acid and fecal fat excretion in normolipidemic subjects. Clin. Chim. Acta 62: 117–123, 1975.
Mishkel, MA: Tibric acid. Its use in 26 hyperlipidemic subjects. Excerpta Medica (in press).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Mishkel, M.A., Hull, L. (1977). Results of Treatment of Hyperlipidemias; Short Term Effect on Cholesterol Metabolism. In: Manning, G.W., Haust, M.D. (eds) Atherosclerosis. Advances in Experimental Medicine and Biology, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4220-5_135
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4220-5_135
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4222-9
Online ISBN: 978-1-4613-4220-5
eBook Packages: Springer Book Archive